Company Description
When a drug is a mere twinkle in a scientist's eye, Compugen is there. The Israeli drug discovery company uses its expertise in computer sciences...
Key Compugen Financials
| Company Type | Public - NASDAQ (GM): CGEN; Exchange: Tel Aviv Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $0.2 |
| 2005 Employees | 121 |
More Compugen Financials (10 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is...
Read more about Compugen's competition across multiple industries
Top Compugen Competitors
Sponsored Links
The Business DirectoryCompugen Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Martin S. Gerstel | Network | E-mail |
| VP Business Development | Eli Zangvil | Network | E-mail |
| President, CEO, and Director | Alex Kotzer | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current Compugen News
- Andromeda Biotech Announces Teva Pharmaceutical Industries Decision to Exercise their Option and Invest in the Lead Product, DiaPep 277, Late Stage... [Diabetes Week] (08 Sep 2008 00:01:00 EDT)
- BioWorld Today August 26, 2008 [BioWorld Today] (26 Aug 2008 00:01:00 EDT)
- NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS [European Patents] (18 Aug 2008 16:03:00 EDT)
Sponsored Opportunity









